13F filer · CIK 1398346 ↗
Meitav Investment House Ltd
You are looking at Q1 2019. See the latest, Q3 2026 →
Reported value
$1.78B
+10% on the quarter before
Positions
390
88 new · 34 sold out
Top 10
37.0%
of the value
Est. gain
+$207.8M
on stocks held all quarter
Est. return
+17.2%
on those stocks since Q4 2018
Positions as of Mar 31, 2019, from Meitav Investment House Ltd's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 57% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2018. Striped tiles are options.
Largest buys
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr~$62.1MAdded · 3.1% → 6.7%+218,299 shares
- Raytheon Co~$26.3MNew · 0.0% → 1.5%+144,648 shares
- Select Sector SPDR Tr~$24.8MAdded · 2.6% → 4.0%+442,778 shares
- Ishares Tr~$22.3MNew · 0.0% → 1.3%+633,990 shares
- Alphabet~$16.2MAdded · 0.9% → 1.8%+13,761 shares
- Dowdupont Inc~$14.5MNew · 0.0% → 0.8%+271,903 shares
- Jd Com Inc~$12.4MNew · 0.0% → 0.7%+410,448 shares
- Select Sector SPDR Tr~$11.8MAdded · 0.0% → 0.7%+158,858 shares
- Select Sector SPDR Tr~$11.6MAdded · 1.3% → 2.0%+125,984 shares
- Ishares Tr~$10.9MAdded · 0.6% → 1.2%+307,825 shares
Largest sells
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Orbotech Ltd~$36.7MCut · 2.0% → 0.1%−558,393 shares
- Israel Chemicals Ltd~$33.7MCut · 2.8% → 1.1%−6,395,234 shares
- Ishares Tr~$28.1MCut · 1.8% → 0.1%−844,160 shares
- Vaneck Vectors ETF Tr~$22.3MCut · 1.3% → 0.0%−368,299 shares
- Meta~$19.7MCut · 1.2% → 0.3%−119,081 shares
- Nutrien Ltd~$19.7MCut · 1.1% → 0.0%−372,908 shares
- Vanguard World Fds~$16.0MCut · 2.6% → 1.8%−191,928 shares
- Select Sector SPDR Tr~$14.7MCut · 1.7% → 0.9%−222,810 shares
- Goldman Sachs~$14.3MCut · 0.8% → 0.0%−74,556 shares
- Nvidia~$14.0MCut · 0.8% → 0.2%−78,836 shares
Holdings
As of Mar 31, 2019. Changes are in shares against Dec 31, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ishares TrCORE S&P500 ETF · shares +108% · price +13.1% | 6.7% | $119.5M | +$6.6M | ||||||||
| Mellanox Technologies LtdSHS · shares −9.0% · price +28.5% | 5.2% | $92.5M | +$20.5M | ||||||||
| Select Sector SPDR TrSBI INT-FINL · shares +13% · price +8.1% | 5.1% | $91.8M | +$6.1M | ||||||||
| Select Sector SPDR TrSBI CONS STPLS · shares +54% · price +10.5% | 4.0% | $71.2M | +$4.4M | ||||||||
| Mylan N VSHS EURO · shares −1.1% · price +5.4% | 3.9% | $69.4M | +$3.5M | ||||||||
| Solaredge Technologies IncCOM · shares −12% · price +7.4% | 3.9% | $69.1M | +$4.7M | ||||||||
| Vanguard Intl Equity Index FFTSE EMR MKT ETF · shares +3.1% · price +11.5% | 2.5% | $45.1M | +$4.5M | ||||||||
| Select Sector SPDR TrSBI HEALTHCARE · shares +48% · price +9.7% | 2.0% | $35.5M | +$2.1M | ||||||||
| Ishares TrEXPANDED TECH · shares −7.7% · price +21.5% | 1.8% | $33.0M | +$5.8M | ||||||||
| Vanguard World FdsCOMM SRVC ETF · shares −33% · price +12.8% | 1.8% | $32.2M | +$3.6M | ||||||||
| AlphabetCAP STK CL A · shares +102% · price +12.8% | 1.8% | $32.1M | +$1.8M | ||||||||
| Kraneshares TrBOSERA MSCI CH · shares −4.5% · price +30.4% | 1.6% | $28.8M | +$6.7M | ||||||||
| Mosaic Co NewCOM · shares +25% · price −5.3% | 1.5% | $27.2M | −$1.2M | ||||||||
| AmazonCOM · shares +14% · price +18.6% | 1.5% | $26.8M | +$3.7M | ||||||||
| CiscoCOM · shares −19% · price +24.5% | 1.5% | $26.4M | +$5.2M | ||||||||
| Raytheon CoCOM NEW · shares New | 1.5% | $26.3M | — | ||||||||
| Perrigo Co PlcSHS · shares −13% · price +61.5% | 1.4% | $25.8M | +$9.8M | ||||||||
| MicrosoftCOM · shares −24% · price +17.6% | 1.4% | $25.4M | +$3.8M | ||||||||
| Check Point Software Tech LtORD · shares −2.0% · price +24.8% | 1.3% | $23.4M | +$4.6M | ||||||||
| Ishares TrUS HOME CONS ETF · shares New | 1.3% | $22.3M | — | ||||||||
| Select Sector SPDR TrSBI INT-INDS · shares −4.8% · price +16.5% | 1.2% | $22.2M | +$3.2M | ||||||||
| Ishares TrMSCI INDIA ETF · shares +98% · price +5.7% | 1.2% | $21.9M | +$599,228 | ||||||||
| Urogen Pharma LtdCOM · shares +35% · price −14.2% | 1.2% | $20.9M | −$2.6M | ||||||||
| Intec Pharma Ltd JerusalemSHS · shares −1.1% · price −2.7% | 1.1% | $20.2M | −$551,704 | ||||||||
| Ormat Technologies IncCOM · shares −10% · price +43.4% | 1.1% | $20.1M | +$6.1M | ||||||||
| Total · 390 positions | 100% | $1.78B | +$207.8M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2018 to Q1 2019: 302 stocks held throughout, up $207.8M (+17.2%).
- Mellanox Technologies Ltd+$20.5M+29%
- Perrigo Co Plc+$9.8M+62%
- Elbit Sys Ltd+$7.0M+323%
- Kraneshares Tr+$6.7M+30%
- Ishares Tr+$6.6M+13%
- Ra Med Sys Inc−$391,766−53%
- Intec Pharma Ltd Jerusalem−$551,704−3%
- Xpo Logistics Inc−$602,707−6%
- Mosaic Co New−$1.2M−5%
- Urogen Pharma Ltd−$2.6M−14%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 28, 2026 | $15.54B+5% | SEC ↗ |
| Q2 2026 | Jul 20, 2026 | $14.87B+63% | SEC ↗ |
| Q1 2026 | Apr 29, 2026 | $9.12B+5% | SEC ↗ |
| Q4 2025 | Feb 10, 2026 | $8.66B+14% | SEC ↗ |
| Q3 2025 | Oct 29, 2025 | $7.57B+2% | SEC ↗ |
| Q2 2025 | Jul 23, 2025 | $7.42B+37% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $5.43B−8% | SEC ↗ |
| Q4 2024 | Feb 3, 2025 | $5.93B−1% | SEC ↗ |
| Q3 2024 | Oct 28, 2024 | $5.97B+6% | SEC ↗ |
| Q2 2024 | Jul 29, 2024 | $5.62B+10% | SEC ↗ |
| Q1 2024 | May 1, 2024 | $5.10B−25% | SEC ↗ |
| Q4 2023 | Jan 29, 2024 | $6.81B+10% | SEC ↗ |
| Q3 2023 | Oct 30, 2023 | $6.17B−50% | SEC ↗ |
| Q2 2023 | Jul 24, 2023 (amended) | $12.45B+115% | SEC ↗ |
| Q1 2023 | May 11, 2023 | $5.79B−1% | SEC ↗ |
| Q4 2022 | Feb 6, 2023 | $5.82B+3% | SEC ↗ |
| Q3 2022 | Oct 31, 2022 | $5.67B−3% | SEC ↗ |
| Q2 2022 | Aug 1, 2022 | $5.86B−13% | SEC ↗ |
| Q1 2022 | May 9, 2022 | $6.74B+10% | SEC ↗ |
| Q4 2021 | Feb 8, 2022 | $6.14B+1% | SEC ↗ |
| Q3 2021 | Nov 3, 2021 | $6.10B−22% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 (amended) | $7.81B+119% | SEC ↗ |
| Q1 2021 | May 6, 2021 | $3.57B+40% | SEC ↗ |
| Q4 2020 | Feb 2, 2021 | $2.55B+27% | SEC ↗ |
| Q3 2020 | Nov 5, 2020 | $2.02B+21% | SEC ↗ |
| Q2 2020 | Aug 10, 2020 | $1.67B+25% | SEC ↗ |
| Q1 2020 | May 11, 2020 | $1.34B−3% | SEC ↗ |
| Q4 2019 | Feb 10, 2020 | $1.38B−1% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $1.39B−7% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $1.50B−16% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $1.78B+10% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $1.62B−21% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $2.05B−8% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.24B+14% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $1.97B+15% | SEC ↗ |
| Q4 2017 | Feb 15, 2018 | $1.71B | SEC ↗ |